Denali Therapeutics (DNLI) Stock Highlights

30.76 | +0.26%

2024-09-19 01:11:58

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The companys development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinsons disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

Statistics

Range Today

30.6 32.13

Volume Today 1.22M

Range 1 Year

14.56 31.15

Volume 1 Year 273.97M

Range 3 Year

14.56 56.08

Volume 3 Year 600.09M

Range 10 Year

12.32 93.94

Volume 10 Year 1.07B

Highlights

Market Capitalization 4.41B (mid)

Floating Shares 123.73M

Current Price 30.76

Price To Earnings -8.89

Price To Revenue 2.81K

Price To Book 3.18

Earnings Per Share -3.15

Payout Ratio 0%

Performance

Latest +0.26%

1 Month +33.97%

3 Months +49.61%

6 Months +53.03%

1 Year +32.13%

3 Years -39.85%

5 Years +61.98%

10 Years +42.74%

Benchmarks

Market Capitalization

57 / 368

Gross Profits

266 / 278

Total Revenue

35 / 300

Total Rank

106 / 368

Free Cashflow

337 / 352

Performance 5 years

87 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.